UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol

PloS one, 2024-03, Vol.19 (3), p.e0294018-e0294018

2024

Volltextzugriff (PDF)

Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors

European journal of cancer (1990), 2024-05, Vol.202, p.114010-114010, Article 114010

2024

Volltextzugriff (PDF)

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

European journal of cancer (1990), 2016-01, Vol.53, p.155-162

2016

Volltextzugriff (PDF)

A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

Annals of oncology, 2016-01, Vol.27 (1), p.140-147

2016

Volltextzugriff (PDF)

Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience

Clinical and translational radiation oncology, 2023-03, Vol.39, p.100562-100562, Article 100562

2023

Volltextzugriff (PDF)

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

BJS open, 2021-11, Vol.5 (6)

2021

Volltextzugriff (PDF)

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

Cancers, 2022-12, Vol.14 (24), p.6238

2022

Volltextzugriff (PDF)

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

Annals of oncology, 2013-09, Vol.24 (9), p.2335-2341

2013

Volltextzugriff (PDF)

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2015-12, Vol.107 (12), p.djv258-djv258

2015

Volltextzugriff (PDF)

Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients

International journal of oncology, 2014-09, Vol.45 (3), p.1293-1303

2014

Volltextzugriff (PDF)

Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

European journal of surgical oncology, 2018-07, Vol.44 (7), p.983-990

2018

Volltextzugriff (PDF)

Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study

Annals of surgery, 2018-02, Vol.267 (2), p.326-331

2018

Volltextzugriff (PDF)

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial

International journal of cancer, 2017-01, Vol.140 (2), p.431-439

2017

Volltextzugriff (PDF)

A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-07, Vol.16 (4), p.640-645

2016

Volltextzugriff (PDF)

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Annals of oncology, 2009-06, Vol.20 (6), p.1057-1061

2009

Volltextzugriff (PDF)

Why is intravenous chemotherapy cancelled and how often. Could it be prevented? A prospective analysis of all planned and given intravenous anti-tumor treatments at the Department of Oncology, Karolinska University Hospital, Stockholm during one month

Acta oncologica, 2015-07, Vol.54 (7), p.1056-1062

2015

Volltextzugriff (PDF)

Palliative treatment of pancreatic adenocarcinoma in a real-world setting

JOURNAL OF CLINICAL ONCOLOGY, 2018, Vol.36 (15_suppl), p.e16243-e16243

2018

Volltextzugriff (PDF)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

ESMO open, 2022-06, Vol.7 (3), p.100427-100427, Article 100427

2022

Volltextzugriff (PDF)

Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor

Clinical cancer research, 2019-05, Vol.25 (9), p.2939-2939

2019

Volltextzugriff (PDF)

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

Acta oncologica, 2016, Vol.55 (2), p.140-148

2016

Volltextzugriff (PDF)

Molecular treatment stratification in second-line treatment of pancreatic adenocarcinoma: PePaCaKa-001

ANNALS OF ONCOLOGY, 2018-09, Vol.29, p.vi31-vi31

2018

Volltextzugriff (PDF)

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

Acta oncologica, 2011-04, Vol.50 (3), p.441-447

2011

Volltextzugriff (PDF)

Assessment of testicular dose during preoperative radiotherapy for rectal cancer

Acta oncologica, 2016, Vol.55 (4), p.496-501

2016

Volltextzugriff (PDF)

Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study

JOURNAL OF CLINICAL ONCOLOGY, 2018, Vol.36 (15_suppl), p.e16214-e16214

2018

Volltextzugriff (PDF)

A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families

Hereditary cancer in clinical practice, 2018-10, Vol.16 (1), p.16-11, Article 16

2018

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(103)
Französisch
(18)

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(83)
Science & Technology
(79)
Life Sciences & Biomedicine
(78)
Humans
(77)
Oncology
(65)
Male
(57)
Female
(55)
Middle Aged
(50)
Aged
(49)
Biological And Medical Sciences
(46)
Medical Sciences
(45)
Adult
(41)
Pharmacology. Drug Treatments
(32)
Antineoplastic Agents
(31)
Antibodies, Monoclonal - Therapeutic Use
(27)
Immunotherapy
(25)
Tumors
(24)
Colorectal Neoplasms - Immunology
(21)
Colorectal Neoplasms - Therapy
(20)
Aged, 80 And Over
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol

Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer

Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients

Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial

A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Why is intravenous chemotherapy cancelled and how often. Could it be prevented? A prospective analysis of all planned and given intravenous anti-tumor treatments at the Department of Oncology, Karolinska University Hospital, Stockholm during one month

Palliative treatment of pancreatic adenocarcinoma in a real-world setting

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

Molecular treatment stratification in second-line treatment of pancreatic adenocarcinoma: PePaCaKa-001

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

Assessment of testicular dose during preoperative radiotherapy for rectal cancer

Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study

A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families

Suchergebnisse filtern